Arena responds to FDA concerns on weight loss drug (Reuters, 3 January 2011)

05 Jan 2012


Arena Pharmaceuticals Inc has responded to the US Food and Drug Administration (FDA) regarding safety concerns expressed by the FDA over the experimental weight-loss drug lorcaserin's New Drug Application.

Full article


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story